Christina Baik, MD MPH
Dr. Christina Baik is an Associate Professor for the University of Washington / Fred Hutchinson Cancer Research Center in Seattle, Washington and a medical oncologist for the Thoracic Head and Neck Oncology group at the Seattle Cancer Care Alliance. She received her MD from the University of Rochester School of Medicine in Rochester, New York and her Masters in Public Health from Harvard School of Public Health, Boston, Massachusetts. She completed her Hematology-Oncology clinical fellowship at Tufts Medical Center, Boston, MA and completed her post-doctorate fellowship at the Fred Hutchinson Cancer Research Center, Seattle, WA. Her clinical and research interest is in thoracic malignancies, especially in the development of novel targeted therapeutics in patients with driver genetic alterations.
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:AstraZenecaTopic:ConsultingDate added:07/01/2024Date updated:07/01/2024Relationship end date:06/06/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:DaiichiTopic:ConsultingDate added:07/01/2024Date updated:07/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:BMSTopic:ConsultingDate added:07/01/2024Date updated:07/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:PfizerTopic:ConsultingDate added:07/01/2024Date updated:07/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:BoehringerTopic:ConsultingDate added:07/01/2024Date updated:07/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:GenentechTopic:ConsultingDate added:07/01/2024Date updated:07/01/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:JansenTopic:ConsultingDate added:07/01/2024Date updated:07/01/2024
-
Attribution:OtherType of financial relationship:OtherIneligible company:BlueprintTopic:Clinical trial fundingDate added:07/01/2024Date updated:07/01/2024
-
Attribution:OtherType of financial relationship:OtherIneligible company:DaiichiTopic:Clinical trial fundingDate added:07/01/2024Date updated:07/01/2024
-
Attribution:OtherType of financial relationship:OtherIneligible company:NuvalentTopic:Clinical trial fundingDate added:07/01/2024Date updated:07/01/2024